Olfactory Training on Smell Dysfunction Patients in HK

May 28, 2025 updated by: Fergus Wong Kai Chuen, Pamela Youde Nethersole Eastern Hospital

Effect of Olfactory Training on Olfactory Dysfunction Patients in Hong Kong Population

  • Causes of olfactory dysfunction can be classified into conductive and sensorineural causes.
  • Conductive causes are mainly due to structural nasal problem, which can be treated by nasal surgery
  • Sensorineural causes included post-infection, post-head injury, post Head and Neck irradiation and other central nervous system diseases.
  • Olfactory Training is well established treatment for sensorineural olfactory dysfunction in foreign countries.
  • Olfactory Training by neurological chemosensory stimulation using aromatic substances delivered via electronic portable aromatic rehabilitation (EPAR) diffuser was proved to be effective treatment in COVID-19 related olfactory dysfunction in recent Hong Kong study.
  • However, there is a lack of local study on the effect of Olfactory Training in other non-COVID-19 sensorineural causes of olfactory dysfunction in Hong Kong population.

Study Overview

Detailed Description

Design Prospective double-blinded randomized control trial.

Study Period 1/7/2022 - 30/6/2024 for case recruitment.

Suitable patient will be recruited. Informed consent will be signed. Objective smell assessment will be done using the University of Pennsylvania Smell Identification Test (UPSIT) and Butanol Threshold Test (BTT). Subjective quality of life score will be obtained by Sino-Nasal Outcome Test (SNOT-22). Subjective smell and taste assessment will be assessed by Visual Analogue Scale (VAS). Patient will be randomized into treatment group and control group using computer generated list by an independent nursing staff. Doctors and the patients will be blinded during the study.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Kai Chuen Fergus Wong, FRCSEd(ORL)
  • Phone Number: 64600771
  • Email: wkc568@ha.org.hk

Study Contact Backup

  • Name: Ka Chung Kwan, FRCSEd(ORL)
  • Phone Number: 64600056

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Pamela Youde Nethersole Eastern Hospital
        • Contact:
          • Kai-Chuen, Fergus Wong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Olfactory dysfunction > 6 months and < 5 years

Exclusion Criteria:

  • History of significant head injury (fracture, ICH)
  • History of brain surgery
  • History of nasal surgery
  • Active nasal disease
  • Active neurological disease
  • Poor premorbid status/ non-communicable patients
  • Mentally incompetent patients
  • <18 years' old
  • Pregnancy
  • Hypersensitivity to the aromatic substance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment arm
Olfactory training by neurological chemosensory stimulation using aromatic substances delivered via diffusers. Four aromatic substances will be used. Each substance will be given for 20 seconds sequentially, providing a total of 80 seconds of olfactory stimulation three times per day for 3 months.
Four aromatic substances will be used (Citrus limon, Eucalyptus radiata, Pelargonium graveolens, Juniperus virginiana)
Placebo Comparator: Control arm
Same diffuser will be given to control group. All of the four essential oils will be replaced by normal saline using the same packing. Same treatment regime of 20 seconds for each diffuser three times per day for 3 months will be instructed to control group patients.
Normal Saline will be used

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Olfactory threshold changes after olfactory training after 3 months
Time Frame: 3 months after starting smell training

Parameter:

Olfactory threshold using Butanol Threshold Test (BTT)

3 months after starting smell training
Olfactory identification score changes after olfactory training after 3 months
Time Frame: 3 months after starting smell training

Parameter:

Olfactory identification using Smell Identification Test (UPSIT)

3 months after starting smell training
Quality of life changes after olfactory training after 3 months
Time Frame: 3 months after starting smell training

Parameter:

Subjective quality of life score using Sino-Nasal Outcome Test (SNOT-22)

3 months after starting smell training
Taste and smell changes after olfactory training after 3 months
Time Frame: 3 months after starting smell training

Parameter:

Subjective smell and taste assessment using Visual Analogue Scale (VAS)

3 months after starting smell training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kai Chuen Fergus Wong, FRCSEd(ORL), Pamela Youde Nethersole Eastern Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

April 14, 2022

First Submitted That Met QC Criteria

May 3, 2022

First Posted (Actual)

May 6, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2025

Last Update Submitted That Met QC Criteria

May 28, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • OlfactoryTrainingHKRCT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe